Taiwan Bio Therapeutics Co., Ltd (6892.TWO)
TWD 29.5
(1.72%)
TWD 29.5
(1.72%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 941.76 Million TWD | 8.12% |
| 2022 | 871.01 Million TWD | 47.6% |
| 2021 | 590.13 Million TWD | 195.61% |
| 2020 | 199.63 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 1.04 Billion TWD | 20.51% |
| 2023 FY | 941.76 Million TWD | 8.12% |
| 2023 Q4 | 941.76 Million TWD | -10.28% |
| 2022 FY | 871.01 Million TWD | 47.6% |
| 2022 Q4 | 871.01 Million TWD | 0.0% |
| 2021 FY | 590.13 Million TWD | 195.61% |
| 2020 FY | 199.63 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 67.535% |
| Level Biotechnology Inc. | 822.67 Million TWD | -14.476% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -41.677% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -71.62% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 75.815% |
| GlycoNex Incorporation | 1.55 Billion TWD | 39.351% |
| VBI | 452.1 Million TWD | -108.307% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 19.928% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -25.808% |
| Visgeneer Inc. | 397.17 Million TWD | -137.114% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 75.022% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 56.38% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -6.643% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 84.543% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1180.297% |
| Enimmune corporation | 604.82 Million TWD | -55.707% |
| TaiRx, Inc. | 833.74 Million TWD | -12.955% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 69.483% |
| EirGenix Inc. | 11.16 Billion TWD | 91.563% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -64.316% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 45.002% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 73.816% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 10.35% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -212.844% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -255.842% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -113.459% |
| RBC Bioscience Corporation | 753.79 Million TWD | -24.937% |
| BiOptic Inc. | 613.77 Million TWD | -53.438% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 47.053% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 18.794% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -46.044% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 69.682% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -635.481% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -148.905% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 16.941% |
| Neith Corporation | 192.15 Million TWD | -390.11% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -536.609% |
| NaviFUS Corp. | 490.53 Million TWD | -91.987% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 23.166% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 30.924% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -77.978% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 18.911% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 43.14% |
| AP Biosciences Inc | 890.75 Million TWD | -5.726% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 88.956% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -190.534% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 29.384% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 65.262% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 93.87% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -129.553% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -137.308% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 54.634% |
| TCI GENE Inc. | 1.16 Billion TWD | 19.227% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -219.695% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 30.922% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -34.836% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 76.182% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 75.364% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 23.424% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 83.195% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 11.323% |
| Acepodia, Inc. | 6.81 Billion TWD | 86.188% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 75.388% |